Human genetics: Lessons from Quebec populations

Annual Review of Genomics and Human Genetics

Volumn 2, Issue , 2001, Pages 69-101

  Scriver, Charles R ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Demography; Founder effect; Genetic drift; Linkage disequilibrium; Mendelian disease; Population structure; Rare alleles

Indexed keywords

ALLELE; ATAXIA; BETA THALASSEMIA; CANADA; CYSTIC FIBROSIS; DEMOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FOUNDER EFFECT; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENEALOGY; GENETIC DISORDER; GENETIC DRIFT; GENETIC MODEL; GENETIC SCREENING; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN GENETICS; HYPERLIPOPROTEINEMIA TYPE 1; IMMIGRATION; INBREEDING; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PENETRANCE; PHENYLKETONURIA; POPULATION GENETICS; POPULATION STRUCTURE; REVIEW; RICKETS; TAY SACHS DISEASE; TYROSINEMIA;

GENETIC DISEASES, INBORN; GENETICS, MEDICAL; GENETICS, POPULATION; HUMANS; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; QUEBEC;

ATAXIA;

EID: 0035776760     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.2.1.69     Document Type: Review

References (172)

1. Abadie V, Lyonnet S, Melle D, Berthelon M, Caillaud C, et al. 1993. Molecular basis of phenylketonuria in France Dev. Brain Dysfunct. 6:120-26
2. Abeliovich D, Lavon IP, Lerer I, Cohen T, Springer C, et al. 1992. Screening for five mutations detects 97% of CF chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am. J. Hum. Genet. 51:951-56
3. Agsteribbe E, van Faassen H, Hartog MV, Reversma T, Taanman J-W, et al. 1990. Nucleotide sequence of cDNA encoding human fumarylacetoacetase. Nucleic Acids Res. 18:1887
4. Andermann E, Scriver CR, Wolfe LS, Dansky L, Andermann F. 1977. Genetic variants of Tay-Sachs disease: Tay-Sachs disease and Sandhoff's disease in French Canadians, juvenile Tay-Sachs disease in Lebanese Canadians, and a Tay-Sachs screening program in the French-Canadian population. Prog. Clin. Biol. Res. 18:161-88
5. Antonarakis SE, Nomencl. Work. Group. 1998. Recommendations for a nomenclature system for human gene mutations. Hum. Mutat. 11:1-3
6. Arnason E, Sigurgislason H, Benedikz E. 2000. Genetic homogeneity of Icelanders: Fact or fiction? Nat. Genet. 25:373-74
7. Arnaud C, Maijer R, Reade T, Scriver CR, Whelan DT. 1970. Vitamin D dependency: An inherited postnatal syndrome with secondary hyperparathyroidism. Pediatrics 46:871-80
8. Austerlitz F, Heyer E. 1998. Social transmission of reproductive behaviour increases frequency of inherited disorders in a young expanding population. Proc. Natl. Acad. Sci. USA 95:15140-44
9. Austerlitz F, Heyer E. 1999. Impact of demographic distribution and population growth rate on haplotypic diversity linked to a disease gene and their consequences for the estimation of recombination rate: Example of a French Canadian population. Genet. Epidemiol. 16:2-14
10. Bergeron J, Normand T, Bharucha A, Ven Murthy MR, Julien P, et al. 1992. Prevalence, geographical distribution and genealogical investigations of mutations 188 of lipoprotein lipase gene in the French Canadian population of Quebec. Clin. Genet. 41:206-10
11. Betard C, Kessling AM, Roy M, Chamberland A, Lussier-Cancan S, Davignon J. 1992. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians. Hum. Genet. 88:529-36
12. Blumen SC, Brais B, Korczyn AD, Medinsky S, Chapman J, et al. 1999. Homozygotes for oculopharnygeal muscular dystrophy have a severe form of the disease. Ann. Neurol. 46:115-18
13. Bodmer WF. 2001. Population genetics. See Ref. 151, pp. 299-310
14. Boehnke M. 2000. A look at linkage disequilibrium. Nat. Genet. 25:246-47
15. e siècles). Cah. Géogr. Québec 32:27-47
16. Bouchard G, De Braekeleer M, eds. 1991. Histoire d'un Gènome. Population et Génétique dans L'est du Québec. Sillery, Québec: Presses Univ. Qué. 607 pp.
17. Bouchard G, Laberge C, Scriver CR. 1992. Comportements démographiques et effets fondateurs dans la population du Québec (XVIIe-XXe siècles). In Anonymous Societé Belge de Demographie Historiens et Populations: Liber Amicorum Etienne Hélin. Louvain-1a-Neuve: Academia
18. Bouchard G, Roy R, Casgrain B, Hubert M. 1995. Computer in human sciences: From family reconstitution to population reconstruction. In From Information to Knowledge. Conceptual and Content Analysis by Computer, ed. E Nissan, KM Schmidt. Oxford: Intellect. 201 pp.
19. Brais B. 1998. Oculopharyngeal Muscular Dystrophy: From Phenotype to Genotype. PhD thesis. McGill Univ., Montréal, Qué.
20. Brais B, Bouchard J-P, Xie YG, Rochefort DL, Tomé FM, et al. 1998. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet. 18:164-67
21. Brais B, Rouleau GA, Bouchard J-P, Fardeau M, Tomé FM. 1999. Oculopharyngeal muscular dystrophy. Semin. Neurol. 19:59-66
22. Brown C, ed. 1987. The Illustrated History of Canada. Toronto: Lester Orpen-Dennys
23. Brunzell JD, Deeb SS. 2001. Familial Lipoprotein Lipase Deficiency, Apo C-II Deficiency and Hepatic Lipase Deficiency. See Ref. 151, pp. 2789-816
24. Byck S, Morgan K, Blanc L, Scriver CR. 1996. The PAH locus and population genetic variation: The Quebec example. Am. J. Hum. Genet. 59: A.33(Abstr.)
25. Byck S, Morgan K, Tyfield L, Dworniczak B, Scriver CR. 1994. Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum. Mol. Genet. 3:1675-77
26. Carter KC, Byck S, Waters PJ, Richards B, Nowacki PM, et al. 1998. Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: The Quebec experience. Eur. J. Hum. Genet. 6:61-70
27. Casgrain B, Hubert M, Bouchard G, Roy R. 1991. Structure de Gestion et D'exploitation du Fichier-Reseau BALSAC. See Ref. 16, pp. 47-71
28. Cavalli-Sforza L, Menozzi P, Piazza A. 1994. The History and Geography of Human Genes. Princeton, NJ: Princeton Univ. Press
29. Cavalli-Sforza LL, Piazza A. 1993. Human genomic diversity in Europe: A summary of recent research and prospects for the future. Eur. J. Hum. Genet. 1:3-18
30. Chapman NH, Thompson EA. 2001. Linkage disequilibrium mapping: The role of population history, size and structure. Adv. Genet. 42:413-37
31. Charbonneau H. 1984. Essai sur l'évolution démographique du Québec de 1534 à 2034. Cah. Québ. Démogr. 13:5-21
32. Cook R. 1987. The Triumph and Trials of Materialism, 1900-1945. See Ref. 22 pp. 375-466
33. Cotton RGH, Scriver CR. 1998. Proof of "disease-causing" mutation. Hum. Mutat. 12:1-3
34. Couture P, Morrissette J, Gaudet D, Vohl M-C, Gagné C, et al. 1999. Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations. Atherosclerosis 143:145-51
35. Crosby AW. 1986. Ecological Imperialism. The Biological Expansion of Europe 900-1900, pp. 1-368. Cambridge, UK: Cambridge Univ. Press
36. Cystic Fibrosis Genet. Anal. Consort. 1994. Population variation of common cystic fibrosis mutations. Hum. Mutat. 4:167-77
37. Daigneault J, Aubin G, Simard F, De Braekeeler M. 1991. Genetic epidemiology of Cystic Fibrosis in Saguenay-Lac-St-Jean (Quebec, Canada). Clin. Genet. 40:298-303
38. De Braekeleer M. 1991. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). Hum. Hered. 41:141-46
39. De Braekeeler M. 1995. Geographic distribution of 18 autosomal recessive disorders in the French Candian population of Saguenay-Lac-Saint-Jean, Quebec. Ann. Hum. Biol. 22:111-22
40. De Braekeeler M, Daigneault J, Allard C, Simard F, Aubin G. 1996. Genealogy and geographic distribution of CFTR mutations in Saguenay-Lac-Saint-Jean (Quebec, Canada). Ann. Hum. Biol. 23:345-52
41. De Braekeeler M, Dao TN. 1994. Hereditary disorders in the French Canadian population of Quebec. I. In search of founders. Hum. Biol. 66:205-23
42. De Braekeeler M, Dao TN. 1994. Hereditary disorders in the French Canadian population of Quebec. II. Contribution of Perche. Hum. Biol. 66:225-49
43. De Braekeeler M, Dionne C, Gagné C, Julien P, Brun D, et al. 1991. Founder effect in familial hyperchylomicronemia among French Canadians of Quebec. Hum. Hered. 41:168-73
44. De Braekeeler M, Gauthier S. 1996. Autosomal recessive disorders in Saguenay-Lac-Saint-Jean (Quebec, Canada): A study of inbreeding. Ann. Hum. Genet. 60:51-56
45. De Braekeeler M, Gauthier S. 1996. Autosomal recessive disorders in Saguenay-Lac-St-Jean, Quebec: Study of kinship. Hum. Biol. 68:371-81
46. De Braekeeler M, Giasson F, Mathiew J, Roy M, Bouchard J-P, Morgan K. 1993. Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix-Saguenay in northeastern Quebec. Genet. Epidemiol. 10:17-25
47. De Braekeeler M, Hechtman P, Andermann E, Kaplan F. 1992. The French Canadian Tay-Sachs disease deletion mutation: Identification of probable founders. Hum. Genet. 89:83-87
48. De Braekeeler M, Landry T, Cholette A. 1994. Consanguinity and kinship in Down Syndrome in Saguenay-Lac-Saint-Jean (Quebec). Ann. Genet. 37:86-88
49. De Braekeeler M, Larochelle J. 1991. Population genetics of vitamin D-dependent rickets in northeastern Quebec. Ann. Hum. Genet. 55:283-90
50. De Braekeeler M, Mari C, Verlingue C, Allard C, Leblanc JP, et al. 1998. Complete identification of cystic fibrosis transmembrane conductance regulator mutations in the CF population of Saguenay-Lac-Saint-Jean (Quebec, Canada). Clin. Genet. 53:44-46
51. De Braekeeler M, Ross M. 1991. In-breeding in Saguenay-Lac-St-Jean (Quebec, Canada): A study of Catholic church dispensations 1842-1971. Hum. Hered. 41:379-84
52. Degioanni A, Darlu P. 1994. Analysis of the molecular variance at the phenylalanine hydroxylase (PAH) locus. Eur. J. Hum. Genet. 2:166-76
53. Demers SI, Phaneuf D, Tanguay RM. 1914. Hereditary Tyrosinemia Type I: Strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis. Am. J. Hum. Genet. 55:327-33
54. Desjardins L, Rousseau C, Duplain J-M, Vallet J-P, Auger P. 1978. La thalassémie chez les québécois francophones. Can. Med. Assoc. J. 119:709-13
55. DiLella AG, Kwok SCM, Ledley FD, Marvit J, Woo SLC. 1986. Molecular structure and polymorphic map of human phenylalanine hydroxylase gene. Biochemistry 25:743-49
56. Dionne C, Gagné C, Julien P, Murthy MR, Lambert M, et al. 1992. Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Quebec, Canada). Ann. Genet. 35:89-92
57. Dobzhansky T. 1967. On genetic aspects of human evolution. In Proc. 3rd Int. Congr. Hum. Genet., ed. JF Crow, JV Neel, pp. 361-65. Baltimore, MA: Johns Hopkins Press
58. Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum. Mutat. 15:7-12
59. Eisensmith RC, Goltsov AA, O'Neill C, Tyfield LA, Schwartz EI, et al. 1995. Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans. Am. J. Hum. Genet. 56:278-86
60. Engert JC, Bérubé D, Mercier J, Doré C, Lepage P, et al. 2000. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat. Genet. 24:120-25
61. Engert JC, Doré C, Mercier J, Ge B, Bétard C, et al. 1999. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): High-resolution physical and transcript map of the candidate region in chromosome region 13q11. Genomics 62:156-64
62. Evans RG. 1988. "We'll take care of it for you." Health care in the Canadian community. Daedalus 117:155-89
63. a. Falconer DS. 1989. Introduction to Quantitative Genetics. Menlo Park, CA: Addison-Wesley. 3rd ed.
64. Feingold J, Guilloud-Bataille M, Feingold N, Rey F, Berthelon M, Lyonnet S. 1993. Linkage disequilibrium in the human phenylalanine hydroxylase. Dev. Brain. Dysfunct. 6:26-31
65. Fernandes MJG, Kaplan F, Clow CL, Hechtman P, Scriver CR. 1992. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazi Jews. Genet. Epidemiol. 9:169-75
66. Fix A. 1999. Migration and Colonization in Human Microevolution. New York: Cambridge Univ. Press
67. Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, Deluca HF. 1973. Pathogenesis of hereditary vitamin D-dependent rickets: An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N. Engl. J. Med. 289:817-22
68. Fumeron F, Grandchamp B, Fricker J, Krempf M, Wolf L-M, et al. 1992. Presence of the French Canadian deletion in a French patient with familial hypercholesterolemia. N. Engl. J. Med. 326:69
69. Gagné C, Brun L-D, Julien P, Moorjani S, Lupien PJ. 1989. Primary lipoprotein lipase activity deficiency: Clinical investigation of a French Canadian population. Can. Med. Assoc. J. 140:405-11
70. Gaudet D, Tremblay G, Perron P, Moorjani S, Ouadahi Y, Moorjani S. 1995. L'hypercholestérolémie familiale dans l'est du Québec: Une problème de santê publique? L'expérience de la clinique des maladies lipidique du Chicoutimi. Union Méd. Can. 124:54-60
71. Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, et al. 1992. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025-33
72. Gentilcore RL, Measner D, Walder RH, Matthews GJ, Moldofsky B, eds. 1993. Historical Atlas of Canada. Vol. II: The Land Transformed 1800-1891. Toronto: Univ. Toronto Press
73. Glorieux FH, Arabian A, Delvin EE. 1995. Pseudo-vitamin D deficiency: Absence of 25-hydroxyvitamin D 1α-hydroxylase activity in human placenta decidual cells. J. Clin. Endocrinol. Metab. 80:2255-58
74. Goldstein JL, Hazzard WR, Schrott WR, Bierman EL, Motulsky AG, et al. 1973. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest. 52:1533-43
75. Goldstein JL, Hobbs HH, Brown MS. 2001. Familial Hypercholesterolemia. See Ref. 151, pp. 2863-914
76. Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SLC. 1992. Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am. J. Hum. Genet. 51:627-36
77. Goltsov AA, Eisensmith RC, Naughton ER, Jin L, Chakraborty R, Woo SLC. 1993. A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum. Mol. Genet. 2:577-81
78. 2 Gangliosidoses. See Ref. 151, pp. 3827-76
79. Grompe M, St-Louis M, Demers SI, Al-Dhalimy M, Leclerc B, Tanguay RM. 1994. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N. Engl. J. Med. 331:353-57
80. Guldberg P, Levy HL, Hanley WB, Koch R, Matalon R, et al. 1996. Phenylalanine hydroxylase gene mutations in the United States: Report from the Maternal PKU Colloborative Study. Am. J. Hum. Genet. 59:84-94
81. Guldberg P, Rey F, Zschocke J, Romano C, Francois B, et al. 1998. A European multicenter study of phenylalanine hydroxylase deficiency: Classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 63:71-79
82. Harney RF. 1988. "So great a heritage as ours." Immigration and the survival of the Canadian polity. Daedalus 117:51-97
83. Harris RC, Matthews GJ, eds. 1987. Historical Atlas of Canada. Vol. I. From the Beginning to 1800. Toronto: Univ. Toronto Press
84. Hastbacka J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A. 1992. Linkage disequilibrium mapping in isolated founder populations: Diastrophic dysplasia in Finland. Nat. Genet. 2:204-11
85. Hayden MR, De Braekeeler M, Henderson HE, Castelein J. 1992. Molecular geography of inherited lipoprotein metabolism: Lipoprotein lipase deficiency and familial hypercholesterolemia. In Molecular Genetics of Coronary Artery Disease. Candidate Genes and Processes in Atherosclerosis, ed. AJ Lusis, JI Rotter, RS Sparkes, 14:350-62. Basel: Karger
86. Hechtman P, Boulay B, De Braekeleer M, Andermann E, Melanáon S, et al. 1992. The intron 7 donor splice site transition: A second Tay-Sachs disease mutation in French Canada. Hum. Genet. 90:402-6
87. Hechtman P, Kaplan F, Bayleran J, Boulay B, Andermann E, et al. 1990. More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians. Am. J. Hum. Genet. 47:815-22
88. Heyer E. 1995. Genetic consequences of differential demographic behaviour in the Saguenay region, Quebec. Am. J. Phys. Anthropol. 98:1-11
89. Heyer E. 1999. One founder/one gene hypothesis in a new expanding population: Saguenay (Quebec, Canada). Hum. Biol. 71:99-109
90. Heyer E, Tremblay M. 1995. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am. J. Hum. Genet. 56:970-78
91. Heyer E, Tremblay M, Desjardins B. 1997. Seventeenth century European origins of hereditary diseases in the Saguenay population (Quebec, Canada). Hum. Biol. 69:209-25
92. Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL. 1987. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N. Engl. J. Med. 317:734-37
93. John SWM, Rozen R, Laframboise R, Laberge C, Scriver CR. 1989. Novel PKU mutation on haplotype 2 in French-Canadians. Am. J. Hum. Genet. 45:905-9
94. John SWM, Rozen R, Scriver CR, Laframboise R, Laberge C. 1990. Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: Evidence in French-Canadians and a catalog of mutations. Am. J. Hum. Genet. 46:970-74
95. Jomphe M, Bouchard G, Davignon J, De Braekeeler M, Gradie M, et al. 1988. Familial hypercholesterolemia in French Canadians: Geographic distribution and centre of origin of an LDL deletion mutation. Am. J. Hum. Genet. 43:A216 (Abstr.)
96. Jorde LB. 1995. Linkage disequilibrium as a gene-mapping tool. Am. J. Hum. Genet. 56:11-14
97. Kaplan F, Kokotsis G, Capua A, Scriver CR. 1991. Quantification of β-thalassemia genes in Quebec immigrants of Mediterranean, Southeast Asian, and Asian Indian origin. Clin. Invest. Med. 14:325-30
98. Kaplan F, Kokotsis G, De Braekeeler M, Morgan K, Scriver CR. 1990. β-thalassemia genes in French-Canadians: Haplotype and mutation analysis of Portneuf chromosomes. Am. J. Hum. Genet. 46:126-32
99. Kaplan NL, Lewis PO, Weir BS. 1994. Age of the ΔF508 cystic fibrosis mutation. Nat. Genet. 8:216-18
100. Karayan L, Qiu S, Betard C, Dufour R, Roederer G, et al. 1994. Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor gene. Arteroscler. Thromb. 14:1258-63
101. Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR. 1997. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: A metanalysis of genotypephenotype correlations. Am. J. Hum. Genet. 61:1309-17
102. Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox DK, et al. 1989. Identification of the cystic fibrosis gene: Genetic analysis. Science 245:1073-80
103. Kerr D, Holdsworth DW, Laskin SL, Mathews GJ, eds. 1990. Historical Atlas of Canada. Vol. III. Addressing the Twentieth Century. 1891-1961. Toronto: Univ. Toronto Press
104. Khoury MJ, Burke W, Thomson EJ. 2000. Genetics and public health: A framework for the integration of human genetics into public health practice. In Genetics and Public Health in the 21st Century. Using Genetic Information to Improve Health and Prevent Disease, ed. MJ Khoury, W Burke, EJ Thomson, pp. 3-23. Oxford: Oxford Univ. Press
105. Kidd JR, Pakstis AJ, Zhao H, Lu R-B, Okonofua FE, et al. 2000. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am. J. Hum. Genet. 66:1882-99
106. Kruglyak L. 1999. Genetic isolates: Separate but equal? Proc. Natl. Acad. Sci. USA 96:1170-72
107. Kruglyak L. 1999. Prospects for wholegenome linkage disequilibrium mapping of common disease genes. Nat. Genet. 22:139-44
108. Laberge C. 1969. Hereditary tyrosinemia in a French Canadian isolate. Am. J. Hum. Genet. 21:36-45
109. Laberge C. 2000. La médecine génétique en début de siècle. Rech. Santé 24:26-29
110. Labuda M, Labuda D, Korab-Laskowska M, Cole DEC, Zietkiewicz E, et al. 1996. Linkage disequilibrium analysis in young populations: Pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am. J. Hum. Genet. 59:633-43
111. Lahr MM. 2000. Wandering genes. Science 289:2057
112. Lambert DM. 1994. The Genetic Epidemiology of Hyperphenylalaninemia in Quebec. PhD thesis. McGill Univ., Montreal
113. Larochelle J, Mortezai A, Belanger M, TremblayM, Claveau JC, AubinG. 1967. Experience with 37 infants with tyrosinemia. Can. Med. Assoc. J. 97:1051-54
114. Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH. 1990. Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85:1014-23
115. Liberman UA, Marx SJ. 2001. Vitamin D and Other Calciferols. See Ref. 151, pp. 4223-40
116. Lichter-Konecki U, Schlotter M, Konecki DS. 1994. DNA sequence polymorphisms in exonic and intronic regions of the human phenylalanine hydroxylase gene aid in the identification of alleles. Hum. Genet. 94:307-10
117. Lidsky AS, Ledley FD, DiLella AG, Kwok SCM, Daiger SP, et al. 1985. Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am. J. Hum. Genet. 37:619-34
118. Lindblad B, Lindstedt S, Steen G. 1967. On the enzymic defects in hereditary tyrosinemia. Proc. Natl. Acad. Sci. USA 74:4641-45
119. Lyonnet S, Melle D, DeBrakeleer M, Laframboise R, Rey F, et al. 1992. Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France. Am. J. Hum. Genet. 51:191-96
120. Ma Y, Betard C, Roy M, Davignon J, Kessling AM. 1989. Identification of a second French-Canadian LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin. Genet. 36:219-28
121. Martino T, Kaplan F, Diamond S, Oppenheim A, Scriver CR. 1997. Probable identity by descent and discovery of familial relationships by means of a rare β-thalassemia haplotype. Hum. Mutat. 9:86-87
122. McEvedy C, Jones R. 1978. Atlas of World Population History, pp. 283-85. London, UK: Penguin
123. Mitchell GA, Grompe M, Lambert M, Tanguay RM. 2001. Hypertyrosinemia. See Ref. 151, pp. 1777-805
124. Mitchell JJ, Capua A, Clow C, Scriver CR. 1996. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-thalassemia disease carriers in high schools. Am. J. Hum. Genet. 59:793-98
125. Monsalve MV, Henderson H, Roederer G, Julien P, Deeb S, et al. 1990. A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J. Clin. Invest. 86:728-34
126. Moore C. 1987. Illustrated History of Canada. See Ref. 22, pp. 105-88
127. Moorjani S, Roy M, Gagné C, Davignon J, Brun D, et al. 1989. Homozygous familial hypercholesterolemia among French Canadians in Québec province. Arteriosclerosis 9:211-16
128. Morison SE. 1972. Samuel de Champlain. Father of New France. Boston, MA: Little, Brown
129. Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, et al. 1994. The origin of the major cystic fibrosis mutation (ΔF508) in European populations. Nat. Genet. 7:169-75
130. Myerowitz R, Hogikyan ND. 1987. A deletion involving Alu sequences in the β-hexosaminidase α-chain of French Canadians with Tay-Sachs disease. J. Biol. Chem. 262:15396-99
131. Normand T, Bergeron J, Fernandes-Margallo T, Bharucha A, Ven Murthy MR, et al. 1992. Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Quebec. Hum. Genet. 89:671-75
132. Oppenheim A, Oron V, Filon D, Fearon CC, Rachmilewitz EA, et al. 1993. Sporadic alleles, including a novel mutation, characterize β-thalassemia in Ashkenazi Jews. Hum. Mutat. 2:155-57
133. Phaneuf D, Labelle Y, Bérubé D, Arden K, Cavanee W, Gagné R. 1991. Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: Assignment of the gene to chromosome 15. Am. J. Hum. Genet. 48:525-35
134. Piazza A. 1993. Who are the Europeans? Science 260:1767-68
135. a. Pier GB. 2000. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity of Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 97:8822-28
136. Pourdier J, St-Louis M, Lettre F, Gibson K, Prévost C, et al. 1996. Frequency of the IVS12_5G->A splice mutation of the fumarylacetoacetate hydroxylase gene in carriers of hereditary tyrosinemia in the French Canadian population of Saguenay-Lac-St-Jean. Prenat. Diagn. 16:59-64
137. Prévost C, Laframboise R, Bardanis M, Clow C, Lancaster G, et al. 1988. Le gène de la β-thalassémie au Canada français: Relance dans le comté de Portneuf. Union Méd. Can. 118:242-44
138. Richter A, Rioux JD, Bouchard J-P, Mercier J, Mathieu J, et al. 1999. Location score and haplotype analyses of the locus for autosomal recessive spastic ataxia of Charlevoix-Saguenay, in chromosome region 13q11. Am. J. Hum. Genet. 64:768-75
139. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, et al. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066-73
140. Rivard SR, Allard C, Leblanc J-P, Milot M, Aubin G, et al. 2000. Correlation between mutations and age in cystic fibrosis in a French Canadian population. J. Med. Genet. 37:225-27
141. Rommens JM, Iannuzzi MC, Kerem B-S, Drumm ML, Melmer G, et al. 1989. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245:1059-66
142. Rootwelt H, Kvittingen EA, Hoie K, Agsteribbe E, Hartog M, et al. 1992. The human fumaryllacetoacetase gene: Characterisation of restriction fragment length polymorphisms and identification of haplotypes in tyrosinemia type 1 pseudodeficiency. Hum. Genet. 89:229-33
143. Rozen R, De Braekeeler M, Daigneault J, Ferreira-Rajabi L, Gerdes M, et al. 1992. Cystic fibrosis mutations in French Canadians: Three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis. Am. J. Hum. Genet. 42:360-64
144. Rozen R, Ferreira-Rajabi L, Robb L, Colman N. 1995. L206W mutation of the cystic fibrosis gene, relatively frequent in French Canadians, is associated with atypical presentations of cystic fibrosis. Am. J. Med. Genet. 57:437-39
145. Rozen R, Schwartz RH, Hilman BC, Stanislovitis P, Horn GT, et al. 1990. Cystic fibrosis mutations in North American populations of French ancestry: Analysis of Quebec French-Canadian and Louisiana Acadian families. Am. J. Hum. Genet. 47:606-10
146. Rudin R. 1985. The Forgotten Quebecers. A History of English-Speaking Quebec. 1759-1980. Quebec: Inst. Que. Rech. Cult.
147. Schoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, et al. 1992. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am. J. Hum. Genet. 50:222-28
148. Scriver CR. 1967. The phenotypic manifestations of hereditary tyrosinemia and tyrosyluria. Can. Med. Assoc. J. 97:1073-76
149. Scriver CR. 1970. Vitamin D dependency. Pediatrics 45:361-63
150. Scriver CR. 1971. Fondements biologiques de la sensibilité du rachitisme à la vitamine D. Union Med. Can. 100:462-74
151. Scriver CR. 1988. Cases are not incidence and vice versa. Genet. Epidemiol. 5:481-87
152. Scriver CR. 1988. Human genes: Determinants of sick populations and sick patients. Can. J. Public Health 79:222-24
153. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. 2001. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill. 8th ed.
154. Scriver CR, Byck S, Prevost L, Hoang L. 1996. The phenylalanine hydroxylase locus: A marker for the history of phenylketonuria and human genetic diversity. In Variation in the Human Genome. Ciba Found. Symp. No. 197, ed. KM Weiss, pp. 73-96. Chichester: Wiley
155. Scriver CR, Fujiwara TM. 1992. Invited editorial: Cystic fibrosis genotypes and views on screening and both heterogeneous and population related. Am. J. Hum. Genet. 51:943-50
156. Scriver CR, John SMW, Rozen R, Eisensmith R, Woo SLC. 1993. Associations between populations, phenylketonuria mutations and RFLP haplotypes at the phenylalanine hydroxylase locus: An overview. Dev. Brain Dysfunct. 6:11-25
157. Scriver CR, Kaufman S. 2001. Hyperphenylalaninemia: Phenylalanine Hydroxylase Deficiency. See Ref. 151, pp. 1667-724
158. Scriver CR, Laberge C, Clow CL, Fraser FC. 1978. Genetics in medicine. An evolving relationship. Science 200:946-52
159. Scriver CR, Nowacki PM. 1999. Genomics, mutations and the internet: The naming and use of parts. J. Inherit. Metab. Disord. 22:519-30
160. Scriver CR, Tenenhouse HS. 1981. On the heritability of rickets, a common disease (Mendel, mammals and phosphate). Johns Hopkins Med. J. 149:179-87
161. Scriver CR, Waters PJ. 1999. Monogenic traits are not simple. Lessons from phenylketonuria. Trends Genet. 15:267-72
162. St Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. 1997. The 25-hydroxyvitamin D 1 α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res. 12:1552-59
163. Thompson EA, Neel JV. 1997. Allelic disequilibrium and allele frequency distribution as a function of social and demographic history. Am. J. Hum. Genet. 60:197-204
164. Treacy E, Byck S, Clow C, Scriver CR. 1993. Celtic phenylketonuria chromosomes found? Evidence in two regions of Quebec province. Eur. J. Hum. Genet. 1:220-28
165. van Amstel JKP, Bergman AJI, van Beurden EA, Roijers JFM, Peelen T, et al. 1996. Hereditary tyrosinemia type I: Novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship. Hum. Genet. 97:51-59
166. Vohl M-C, Moorjani S, Roy M, Gaudet D, Torres AL, et al. 1997. Geographic distribution of French Canadian low density lipoprotein receptor gene mutations in the province of Quebec. Clin. Genet. 52:1-6
167. Waite P. 1987. Between Three Oceans: Challenges of a Continental Destiny, 1840-1900. See Ref. 22, pp. 279-374
168. Weatherall DJ, Clegg JB, Higgs DR, Wood WG. 2001. The Hemoglobinopathies. See Ref. 151, pp. 4571-636
169. Weiss KM. 1996. Is there a paradigm shift in genetics? Lessons from the study of human diseases. Mol. Phylogenet. Evol. 5:259-65
170. Welsch MJ, Ramsey BW, Accuraso F, Cutting GR. 2001. Cystic Fibrosis. See Ref. 151, pp. 5121-88
171. Wood S, Schertzer M, Hayden M, Ma Y. 1993. Support for founder effect for two lipoprotein lipase (LPL) gene mutations in French Canadians by analysis of GT microsatellites flanking the LPL gene. Hum. Genet. 91:312-16
172. Wynn G. 1987. On the Margins of Empire, 1760-1840. See Ref. 22, pp. 189-278